Literature DB >> 17483097

L1 retrotransposition can occur early in human embryonic development.

José A J M van den Hurk1, Iwan C Meij, Maria del Carmen Seleme, Hiroki Kano, Konstantinos Nikopoulos, Lies H Hoefsloot, Erik A Sistermans, Ilse J de Wijs, Arijit Mukhopadhyay, Astrid S Plomp, Paulus T V M de Jong, Haig H Kazazian, Frans P M Cremers.   

Abstract

L1 elements are autonomous retrotransposons that can cause hereditary diseases. We have previously identified a full-length L1 insertion in the CHM (choroideremia) gene of a patient with choroideremia, an X-linked progressive eye disease. Because this L1 element, designated L1(CHM), contains two 3'-transductions, we were able to delineate a retrotransposition path in which a precursor L1 on chromosome 10p15 or 18p11 retrotransposed to chromosome 6p21 and subsequently to the CHM gene on chromosome Xq21. A cell culture retrotransposition assay showed that L1(CHM) is one of the most active L1 elements in the human genome. Most importantly, analysis of genomic DNA from the CHM patient's relatives indicated somatic and germ-line mosaicism for the L1 insertion in his mother. These findings provide evidence that L1 retrotransposition can occur very early in human embryonic development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483097     DOI: 10.1093/hmg/ddm108

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  93 in total

Review 1.  Active human retrotransposons: variation and disease.

Authors:  Dustin C Hancks; Haig H Kazazian
Journal:  Curr Opin Genet Dev       Date:  2012-03-08       Impact factor: 5.578

2.  Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility.

Authors:  Silke Wissing; Martin Muñoz-Lopez; Angela Macia; Zhiyuan Yang; Mauricio Montano; William Collins; Jose Luis Garcia-Perez; John V Moran; Warner C Greene
Journal:  Hum Mol Genet       Date:  2011-10-11       Impact factor: 6.150

Review 3.  A LINE-1 component to human aging: do LINE elements exact a longevity cost for evolutionary advantage?

Authors:  Georges St Laurent; Neil Hammell; Timothy A McCaffrey
Journal:  Mech Ageing Dev       Date:  2010-03-25       Impact factor: 5.432

4.  Epigenetic control of retrotransposon expression in human embryonic stem cells.

Authors:  Angela Macia; Martin Muñoz-Lopez; Jose Luis Cortes; Robert K Hastings; Santiago Morell; Gema Lucena-Aguilar; Juan Antonio Marchal; Richard M Badge; Jose Luis Garcia-Perez
Journal:  Mol Cell Biol       Date:  2010-11-01       Impact factor: 4.272

5.  Retrotransposition of R2 elements in somatic nuclei during the early development of Drosophila.

Authors:  Michael T Eickbush; Thomas H Eickbush
Journal:  Mob DNA       Date:  2011-09-29

6.  Intact piRNA pathway prevents L1 mobilization in male meiosis.

Authors:  Simon J Newkirk; Suman Lee; Fiorella C Grandi; Valeriya Gaysinskaya; James M Rosser; Nicole Vanden Berg; Cathryn A Hogarth; Maria C N Marchetto; Alysson R Muotri; Michael D Griswold; Ping Ye; Alex Bortvin; Fred H Gage; Jef D Boeke; Wenfeng An
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

7.  The MOV10 helicase inhibits LINE-1 mobility.

Authors:  Xiaoyu Li; Jianyong Zhang; Rui Jia; Vicky Cheng; Xin Xu; Wentao Qiao; Fei Guo; Chen Liang; Shan Cen
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

8.  An epi [c] genetic battle: LINE-1 retrotransposons and intragenomic conflict in humans.

Authors:  Martin Muñoz-Lopez; Angela Macia; Marta Garcia-Cañadas; Richard M Badge; Jose L Garcia-Perez
Journal:  Mob Genet Elements       Date:  2011-07-01

9.  L1 mobile element expression causes multiple types of toxicity.

Authors:  Nicholas A Wallace; Victoria P Belancio; Prescott L Deininger
Journal:  Gene       Date:  2008-05-03       Impact factor: 3.688

Review 10.  Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.

Authors:  Elisa Orecchini; Loredana Frassinelli; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  Chromosome Res       Date:  2018-02-02       Impact factor: 5.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.